These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25576341)

  • 1. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
    Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
    Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-375 targeting autophagy-related 2B (ATG2B) suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells.
    Gao S; Wang K; Wang X
    Neoplasma; 2020 Jul; 67(4):724-734. PubMed ID: 32726125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.
    Cheng DD; Yu T; Hu T; Yao M; Fan CY; Yang QC
    Oncotarget; 2015 Dec; 6(40):42761-72. PubMed ID: 26498360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
    Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H
    Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z; Liu Z; Wu S
    Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells.
    Fujiwara T; Katsuda T; Hagiwara K; Kosaka N; Yoshioka Y; Takahashi RU; Takeshita F; Kubota D; Kondo T; Ichikawa H; Yoshida A; Kobayashi E; Kawai A; Ozaki T; Ochiya T
    Stem Cells; 2014 Apr; 32(4):959-73. PubMed ID: 24715690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
    Xu M; Jin H; Xu CX; Sun B; Mao Z; Bi WZ; Wang Y
    Oncotarget; 2014 Oct; 5(19):9472-83. PubMed ID: 25344865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-603 functions as an oncogene by suppressing BRCC2 protein translation in osteosarcoma.
    Ma C; Zhan C; Yuan H; Cui Y; Zhang Z
    Oncol Rep; 2016 Jun; 35(6):3257-64. PubMed ID: 27035098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
    Liu X; Ma W; Ma J; Xiao L; Hao D
    Pathol Res Pract; 2019 Aug; 215(8):152492. PubMed ID: 31257090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
    Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
    BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-190b inhibits tumor cell proliferation and induces apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells.
    Kang M; Xia P; Hou T; Qi Z; Liao S; Yang X
    Pharmazie; 2017 May; 72(5):279-282. PubMed ID: 29441873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.
    Li ZM; Zhang HY; Wang YX; Wang WB
    J Drug Target; 2016; 24(2):102-10. PubMed ID: 26302771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin.
    Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX
    Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
    Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
    Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal.
    Li QC; Xu H; Wang X; Wang T; Wu J
    Cancer Biomark; 2017 Dec; 21(1):135-144. PubMed ID: 29060932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; D'Anneo A; Carlisi D; De Blasio A; Giuliano M; Tesoriere G; Giordano A; Vento R
    Int J Oncol; 2014 Nov; 45(5):2013-23. PubMed ID: 25174983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
    Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
    Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma.
    Yu L; Meng M; Bao Y; Zhang C; Gao B; Sa R; Luo W
    Yonsei Med J; 2019 Sep; 60(9):832-841. PubMed ID: 31433581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.